QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026
$4.47
· of 52w range
· above low
· to high
$3.2552w low
$41.8052w high
Market Cap (MRQ)
$314M
your badges
52W Range
$3–$42
Analyst Rating
BUY
Price Target
$22
P/E
·
ROE
-201.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
QNRX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.47
Market Cap (MRQ)
$314M
ROE
-201.7%
52W Range
$3–$42
QNRX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| April 9, 2025 | 1-for-35 | Reverse |
| July 18, 2023 | 1-for-12 | Reverse |
| Aug. 1, 2022 | 1-for-12 | Reverse |
| Sept. 24, 2021 | 1-for-4 | Reverse |
| Oct. 23, 2019 | 1-for-5 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | QNRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 79.95Y avg ≈487843.6 | ≈487843.6 | 1.8 | Overvalued | |
| Price / Cash Flow | -22.75Y avg ≈-426067.4 | ≈-426067.4 | · | · | |
| Price / Tangible Book (MRQ) | 87.35Y avg ≈539126.2 | ≈539126.2 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | QNRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -87.6%5Y avg ≈-74.0% | ≈-74.0% | -63.1% | Weak | |
| ROE | -201.7%5Y avg ≈-142.5% | ≈-142.5% | -25.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | QNRX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 1.85Y avg ≈3.5 | ≈3.5 | 3.8 | Low liquidity | |
| Quick Ratio | 3.45Y avg ≈1.4 | ≈1.4 | 2.1 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
7.9%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-1.90 | $-1.64 | -15.7% |
| March 31, 2026 | May 11, 2026 | $-1.77 | $-1.97 | 9.9% |
| Dec. 31, 2025 | $-1.50 | $-3.40 | 55.9% | |
| Sept. 30, 2025 | $-6.71 | $-5.08 | -32.2% | |
| June 30, 2025 | $-6.28 | $-7.56 | 16.9% | |
| March 31, 2025 | $-6.50 | $-6.19 | -5.0% | |
| Dec. 31, 2024 | $-12.25 | $-16.42 | 25.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $10M | $4M | $3M | $3M | $2M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $4M | |
| Other Non-op | $486.1K | $566.0K | $691.9K | $-123.8K | $-15M | |
| Pretax Income | $-16M | $-9M | · | · | · | |
| Net Income | $-16M | $-9M | $-9M | $-9M | $-21M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $2M | $3M | $7M | |
| Short-term Investments | $15M | $10M | · | · | · | |
| Prepaid Expense | $1M | $869.1K | $591.0K | $516.6K | $715.5K | |
| Current Assets | $20M | $15M | $11M | $13M | $8M | |
| Intangibles | $383.3K | $483.3K | $583.3K | $704.6K | $808.6K | |
| Total Assets | $20M | $16M | $12M | $14M | $9M | |
| Accounts Payable | $1M | $905.7K | $526.5K | $605.6K | $923.2K | |
| Accrued Liabilities | $3M | $2M | $1M | $1M | $2M | |
| Current Liabilities | $6M | $4M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | $3M | $4M | · | |
| Total Liabilities | $7M | $7M | $7M | $7M | $9M | |
| Common Stock | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $84M | $64M | $52M | $48M | $32M | |
| Retained Earnings | $-71M | $-55M | $-46M | $-38M | $-28M | |
| Treasury Stock | · | · | · | $3M | $3M | |
| AOCI | $-613 | $55M | $46M | $38M | · | |
| Stockholders' Equity | $13M | $9M | $6M | $7M | $657.0K | |
| Liabilities + Equity | $20M | $16M | $12M | $14M | $9M | |
| Shares Outstanding | 52,441,360 | 8,948,164 | 987,220 | 403,887 | 55,913 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $764.0K | · | |
| Amort. of Intangibles | $100.0K | $100.0K | $104.0K | $104.0K | $104.0K | |
| Operating Cash Flow | $-14M | $-8M | $-8M | $-8M | $-6M | |
| Investing Cash Flow | $-4M | $-2M | $2M | $-10M | $-625.0K | |
| Stock Issued | $19M | $12M | · | · | · | |
| Net Stock Activity | $19M | · | · | · | · | |
| Financing Cash Flow | $18M | $11M | $5M | $14M | $14M | |
| Net Change in Cash | $194.8K | $1M | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -87.6% | -64.3% | -65.2% | -78.8% | · | |
| ROE | -201.7% | -122.4% | -132.8% | -113.2% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.2 | 3.8 | · | |
| Quick Ratio | 3.4 | 0.9 | 0.7 | 0.8 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $0.25 | $1.03 | $5.74 | $0.00 | · | |
| Cash / Share | $0.07 | $0.40 | $2.43 | $0.00 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-9M | $-9M | $-9M | · | |
| Market Cap | $757M | $204M | $169M | $14.45T | · | |
| P/B | 57.7 | 22.1 | 29.9 | 1951264.6 | · | |
| P / Tangible Book | 59.4 | 23.4 | 33.4 | 2156388.6 | · | |
| P / Cash Flow | -55.9 | -25.9 | -21.6 | -1704166.1 | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $587.5K | $885.3K | $832.4K | $758.8K | $625.1K | $1M | $613.1K | $745.5K | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $2M | |
| Other Non-op | $102.5K | $133.5K | $172.1K | $71.8K | $97.2K | $145.0K | $93.8K | $178.1K | $163.1K | $131.0K | $167.8K | $198.5K | $153.1K | $172.5K | $85.0K | $-702.0K | |
| Net Income | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M | $-3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $4M | $2M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $5M | $3M | $3M | · | |
| Short-term Investments | $7M | $11M | $15M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $836.1K | $1M | $1M | $602.7K | $688.9K | $944.1K | $869.1K | $190.5K | $650.7K | $574.9K | $591.0K | $159.9K | $234.2K | $398.9K | $516.6K | · | |
| Current Assets | $12M | $15M | $20M | $6M | $8M | $12M | $15M | $10M | $13M | $15M | $11M | $14M | $16M | $17M | $13M | · | |
| Intangibles | $333.3K | $358.3K | $383.3K | $408.3K | $433.3K | $458.3K | $483.3K | $508.3K | $533.3K | $558.3K | $583.3K | $626.5K | $652.5K | $678.5K | $704.6K | · | |
| Total Assets | $12M | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | · | |
| Accounts Payable | $3M | $2M | $1M | $2M | $873.7K | $644.1K | $905.7K | $222.6K | $819.7K | $358.5K | $526.5K | $240.0K | $707.9K | $281.1K | $605.6K | · | |
| Accrued Liabilities | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $3M | $2M | $2M | $1M | · | |
| Current Liabilities | $7M | $5M | $6M | $6M | $4M | $5M | $4M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | · | |
| Other Non-current Liabilities | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | · | $4M | · | |
| Total Liabilities | $8M | $7M | $7M | $8M | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $7M | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $85M | $85M | $84M | $65M | $65M | $65M | $64M | $58M | $58M | $58M | $52M | $54M | $54M | $54M | $48M | · | |
| Retained Earnings | $-81M | $-76M | $-71M | $-67M | $-63M | $-59M | $-55M | $-53M | $-51M | $-49M | $-46M | $-44M | $-42M | $-40M | $-38M | · | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | $3M | · | |
| AOCI | $-582 | $-159 | $-613 | · | $63M | $59M | · | $-53M | $50M | $48M | · | $44M | $42M | $40M | · | · | |
| Stockholders' Equity | $4M | $9M | $13M | $-1M | $3M | $6M | $9M | $5M | $7M | $9M | $6M | $7M | $9M | $11M | $7M | · | |
| Liabilities + Equity | $12M | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | · | |
| Shares Outstanding | 70,294,615 | 68,642,195 | 52,441,360 | 20,585,830 | 20,585,830 | 20,585,830 | 8,948,164 | 5,049,720 | 3,979,970 | 3,795,970 | 987,220 | 987,220 | 59,233,024,799 | 59,233,024,799 | 403,887 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $533.0K | $444.5K | $283.2K | $182.2K | $321.5K | $360.4K | $326.3K | $313.1K | $313.1K | $306.3K | $300.2K | $268.5K | $264.4K | $261.5K | $267.3K | $267.3K | |
| Amort. of Intangibles | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | |
| Operating Cash Flow | $-3M | $-5M | $-5M | $-2M | $-4M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-1M | $-2M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | $4M | $4M | $-11M | $3M | $2M | $3M | $-3M | $3M | $3M | $-4M | $3M | $821 | $3M | $-3M | $0 | $-10M | |
| Financing Cash Flow | $-151.9K | $56.0K | $18M | $-150.0K | $-150.0K | $23.0K | $6M | $-149.9K | $-136.3K | $5M | $-182.6K | $-275.0K | $-75.0K | $6M | $-446.9K | $15M | |
| Net Change in Cash | $721.1K | $-693.6K | · | · | $-2M | $198.8K | · | · | · | · | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -51.4% | -34.9% | · | -44.3% | -32.2% | -26.2% | · | -41.3% | -13.6% | -13.5% | · | · | -25.2% | -28.2% | · | · | |
| ROE | -165.7% | -68.0% | · | -186.8% | -73.7% | -50.7% | · | -86.4% | -26.5% | -23.2% | · | · | -46.5% | -47.7% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.9 | · | 1.0 | 2.0 | 2.6 | · | 3.0 | 3.3 | 3.6 | · | · | 3.6 | 4.2 | · | · | |
| Quick Ratio | 1.6 | 2.6 | · | 0.3 | 0.4 | 0.8 | · | 0.9 | 0.7 | 0.4 | · | · | 1.1 | 0.8 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.06 | $0.13 | · | $-0.06 | $0.12 | $0.29 | · | $1.08 | $1.88 | $2.40 | · | · | $0.00 | $0.00 | · | · | |
| Cash / Share | $0.05 | $0.05 | · | $0.09 | $0.08 | $0.19 | · | $0.62 | $0.71 | $0.48 | · | · | $0.00 | $0.00 | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-17M | · | $-14M | $-12M | $-10M | · | $-9M | $-8M | $-8M | · | $-9M | $-10M | $-10M | · | · | |
| Market Cap | $340M | $453M | · | $148M | $190M | $161M | · | $87M | $81M | $126M | · | · | $12.44T | $11.84T | · | · | |
| P/B | 86.5 | 51.6 | · | -121.9 | 74.5 | 27.2 | · | 16.0 | 10.8 | 13.8 | · | · | 1371154.2 | 1084972.1 | · | · | |
| P / Tangible Book | 94.5 | 53.8 | · | · | 89.7 | 29.5 | · | 17.7 | 11.6 | 14.7 | · | · | 1477425.3 | 1156896.3 | · | · | |
| P / Cash Flow | · | -93.0 | · | · | · | -62.2 | · | · | · | -88.0 | · | · | · | -6780205.6 | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-16M | $-9M | $-9M | $-9M | $-21M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.2 | 3.8 | · |
| Quick Ratio | 3.4 | 0.9 | 0.7 | 0.8 | · |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 19 filers · $6.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
19
Value held
$6.3M
New positions
1
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (-5 vs prior Q) | 3 (0 vs prior Q) | 9 (+2 vs prior Q) | 3 (-1 vs prior Q) | +115K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | $1,040,537 | 214,987 | 16.55% | Shares |
| Ikarian Capital, LLC | $1,023,844 | 211,538 | 16.28% | Shares |
| Stonepine Capital Management, LLC | $965,512 | 199,486 | 15.35% | Shares |
| MILLENNIUM MANAGEMENT LLC | $543,643 | 112,323 | 8.64% | Shares |
| SummitTX Capital, L.P. | $485,452 | 100,300 | 7.72% | Shares |
| Woodline Partners LP | $369,999 | 76,446 | 5.88% | Shares |
| Aberdeen Group plc | $363,000 | 75,000 | 5.77% | Shares |
| Soleus Capital Management, L.P. | $352,013 | 72,730 | 5.60% | Shares |
| AIGH Capital Management LLC | $338,800 | 70,000 | 5.39% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $289,616 | 59,838 | 4.61% | Shares |
| Velan Capital Investment Management LP | $156,680 | 32,372 | 2.49% | Shares |
| BARCLAYS PLC | $103,910 | 21,469 | 1.65% | Shares |
| Birchview Capital, LP | $96,800 | 20,000 | 1.54% | Shares |
| XTX Topco Ltd | $72,629 | 15,006 | 1.15% | Shares |
| MORGAN STANLEY | $38,720 | 8,000 | 0.62% | Shares |
| UBS Group AG | $32,777 | 6,772 | 0.52% | Shares |
| RHUMBLINE ADVISERS | $11,280 | 2,332 | 0.18% | Shares |
| GAMMA Investing LLC | $2,125 | 439 | 0.03% | Shares |
| SBI Securities Co., Ltd. | $1,718 | 355 | 0.03% | Shares |
Activists & 5%+ owners 3 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Michael Myers ×2 filings | Jan. 28, 2025 | 0.00% | Amendment | Passive investment | SEC |
| Denise Carter ×2 filings | Jan. 28, 2025 | 0.00% | Amendment | Passive investment | SEC |
| Dr. Shai Yarkoni ×3 filings | April 22, 2020 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 9 insiders · 4 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Michael Myers | Chief Executive Officer | Aug. 31, 2026 P | 37,713 | 1 | 0 | $99,991 |
| Sally Bridget Lawlor | Chief Financial Officer | Aug. 31, 2026 P | 10,684 | 1 | 0 | $49,991 |
| Gordon Dunn | Chief Financial Officer | Dec. 23, 2024 P | 151,077 | 0 | 0 | $0 |
| Denise Carter | Chief Operating Officer | Aug. 31, 2026 P | 37,709 | 1 | 0 | $99,991 |
| Anthony James Culverwell | Director | Aug. 31, 2026 P | 40,364 | 1 | 0 | $29,992 |
| Dennis Langer | Director | Aug. 27, 2026 A | 56,243 | 1 | 0 | $128,640 |
| Natalie Ee Mun Leong | Director | Feb. 4, 2026 A | · | 0 | 0 | $0 |
| Joseph Patrick Cooper | Director | Feb. 4, 2026 A | · | 0 | 0 | $0 |
| Michael T Sember | Director | Feb. 4, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
QNRX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$20.00
+347.4%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-09-30Mean target $21.83 +388.4%
← Below all targets
Current price $4.47
Low$12.00
Mean$21.83
High$35.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| QNRX | $757M | · | · | · | -201.7% | · |
| PLRZ | $14M | 1.7 | · | · | -25.4% | · |
| PLUR | $23M | -0.9 | -23.9% | -2344.6% | 159.5% | 44.6% |
| CMMB | · | 91.7 | · | · | -69.5% | · |
| NRSN | $25M | -1.7 | · | · | -2175.0% | · |
| ENLV | $167M | 0.0 | · | · | 126.2% | · |
| EVGN | · | 1.0 | · | -220.2% | 1107.0% | -6.2% |
| CLGN | $18M | -1.5 | · | -484.6% | -117.6% | 64.8% |
| URGN | $1.13B | · | 21.4% | -139.8% | 154.4% | 88.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 14, 2026